Skip to content

Drug interactions

Dihydroergotamine + Pimavanserin

Severity: Moderate

Dihydroergotamine and Pimavanserin: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Pimavanserin acts on serotonin receptors and dihydroergotamine has serotonergic activity, so use together carries a theoretical risk of serotonin toxicity. The dopaminergic effects of the antipsychotic may also add to neuroleptic-type reactions. Clinical evidence is limited.

What this interaction means in plain words

Dihydroergotamine and Pimavanserin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Dihydroergotamine belongs to Central Nervous System; Pimavanserin belongs to Central Nervous System.

Evidence level: Low

Why it happens

Theoretical additive serotonergic and dopaminergic modulation; pimavanserin is a 5-HT2A inverse agonist.

What to do

Monitor for serotonin toxicity (agitation, tremor, hyperthermia, clonus) and neuroleptic malignant syndrome. Educate patients to report these symptoms promptly.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dihydroergotamine and Pimavanserin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Dihydroergotamine with Pimavanserin?

MediHelp rates the interaction as moderate. Dihydroergotamine and Pimavanserin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Pimavanserin acts on serotonin receptors and dihydroergotamine has serotonergic activity, so use together carries a theoretical risk of serotonin toxicity. The dopaminergic effects of the antipsychotic may also add to neuroleptic-type reactions. Clinical evidence is limited.

How serious is the interaction between Dihydroergotamine and Pimavanserin?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for serotonin toxicity (agitation, tremor, hyperthermia, clonus) and neuroleptic malignant syndrome. Educate patients to report these symptoms promptly.

What other medicines interact with Pimavanserin?

MediHelp also lists interactions of Pimavanserin with, for example, Lefamulin, Pimozide, Vandetanib. The full list is on the Pimavanserin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in